Why is Remedium Life falling/rising?

As of 18-Jul, Remedium Lifecare Ltd's stock price is currently flat at 1.20, with no change (0.00%). The stock has shown a positive performance over the past week, increasing by 2.56%, while it has significantly outperformed the sector today by 0.53%. However, despite these short-term gains, the company has reported substantial losses, including a negative return on capital employed (ROCE) and a high debt-to-EBITDA ratio of -1.00 times, indicating a low ability to service debt. The company has also declared negative results for the last three consecutive quarters, with a significant decline in net sales and profit after tax, contributing to a poor long-term growth outlook.
In the broader market context, while Remedium Lifecare has outperformed the Sensex in the short term, with a 1-week return of +2.56% compared to the benchmark's -0.90%, the stock has underperformed over the longer term, generating a staggering -91.06% return over the past year. This stark contrast highlights the stock's volatility and the challenges it faces, including a lack of institutional support and ongoing financial difficulties. Overall, the stock's recent flat price movement reflects a complex interplay of short-term investor interest against a backdrop of significant financial struggles and poor long-term performance.